Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Nature Biotechnology|October 27, 2015
In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicityGeoffrey M Lynn, Richard Laga, Patricia A Darrah, et al.
Internal Medicine Journal|November 13, 2022
Australia and New Zealand Transplant and Cellular Therapies (ANZTCT) position statement: COVID-19 management in patients with haemopoietic stem cell transplant and chimeric antigen receptor T cellJacinta Perram, Duncan Purtill, Ashish Bajel, et al.
IJID Regions|September 16, 2024
Evaluation of risk prediction scores for adults hospitalized with COVID-19 in a highly-vaccinated population, Aotearoa New Zealand 2022Michael James Maze, Jonathan Williman, Rebekah Anstey, et al.
IJID Regions|August 26, 2024
COVID-19-related hospitalizations among Aotearoa, New Zealand children during the Omicron era of SARS-CoV-2Amanda Taylor, Emma J Best, Tony Walls, et al.
Internal Medicine Journal|June 21, 2025
Variation in clinical presentation, complications and outcomes for Māori and Pacific peoples among hospitalised adults with COVID-19 in 2022, Aotearoa New ZealandMichael J Maze, Haylea Rodgers, Jonathan Williman, et al.
Internal Medicine Journal|November 22, 2025
Convalescent plasma in hospitalised patients with COVID-19Zoe McQuilten, Matthew V N O'Sullivan, Damien Purcell, et al.
JAMA|December 16, 2022
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial, Alisa M Higgins, Lindsay R Berry, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 20, 2026
The private solution trap in collective action problems across 34 nationsEugene Malthouse, Charlie Pilgrim, Daniel Sgroi, et al.
JAMA|March 22, 2022
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial, Charlotte A Bradbury, Patrick R Lawler, et al.
JAMA|April 11, 2023
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial, Patrick R Lawler, Lennie P G Derde, et al.
Pageof 8